Economic evaluation of three dialysis methods in patients with end-stage renal disease in China

• Published in: International urology and nephrology 2023-05, Vol.55 (5), p.1247-1254
• Main Authors: Hong, Zhuang, Zhuang, Ye, Lu, Jun, Ye, Jianming, Sun, Heqi, Gao, Lanying, Xiong, Yan
• Format: Article
• Language: English
• Subjects: China - epidemiology; Cost analysis; Cost-Benefit Analysis; Dialysis; Economics; End-stage renal disease; Hemodialysis; Humans; Kidney diseases; Kidney Failure, Chronic - psychology; Markov chains; Medicine; Medicine & Public Health; Nephrology; Nephrology - Original Paper; Per capita; Peritoneal dialysis; Peritoneal Dialysis - methods; Peritoneum; Renal Dialysis - methods; Sensitivity analysis; Urology
• ISSN: 1573-2584; 0301-1623; 1573-2584
• DOI: 10.1007/s11255-022-03402-2

Objectives End-stage renal disease (ESRD) may result in different degrees of physical and psychological pain. Automated peritoneal dialysis (APD), continuous ambulatory peritoneal dialysis (CAPD), and hemodialysis (HD) as the main treatment methods lead to a heavy burden on social economic and family financial. However, there are few studies on the economic evaluation of the three dialysis methods in China. Methods Cost-effectiveness analyses were performed using Markov models based on longitudinal data for 15 years of different modalities in Kunshan City, China. Direct cost derived from medical insurance information system, and indirect cost referred to as loss of productivity. Sensitivity analyses were conducted to study uncertainty. Results The per capita total cost of CAPD was 664,027.00 yuan, the per capita utility is 5.9105. The per capita total cost of APD was 858,800.65 yuan, the per capita utility is 6.4548. The per capita total cost of HD was 1,281,213.64 yuan, the per capita utility is 6.1356. When CAPD was compared with HD, Incremental Cost-Effectiveness Ratio (ICER) was 1,323,389.53 yuan per QALY, compared with APD, ICER was 357,848.13 yuan per QALY. ICER value suggests that APD was cost-effective compared with CAPD and HD at a willingness-to-pay threshold of 538,200 yuan. Conclusion Our research showed that APD is the most appropriate and HD is the worst in terms of cost-effectiveness. However, in fact, HD accounts for a high proportion in China, so some relevant policy suggestions need to be implemented to change the current situation.